InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,719.90
(
1.81%
)
US TECH 100
19,331.20
(
2.51%
)
Dow Jones
42,009.50
(
1.22%
)
Brent Oil
73.94
(
2.15%
)
Bitcoin
63,447.40
(
2.88%
)
Post# of 316926
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

cintrix

Send PM Follow Ignore
Followers 363
Posts 113984
Boards Moderated 5
Alias Born 12/28/2000

cintrix

Member Level

Re: None

Tuesday, 06/27/2017 12:33:43 PM

Tuesday, June 27, 2017 12:33:43 PM

Post# of 316926
ALDR anyone? A migraine treatment developed by Washington-based Alder Biopharmaceuticals appeared to deliver less of a benefit over placebo than rival drugs, sending shares in the biotech down more than 20% in early Tuesday trading even though the Phase 3 study met its goal.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up